Company page

Instil Bio, Inc.

Instil Bio, Inc. is a public company traded under the ticker TIL in the American market. The company has a market capitalization of approximately $50.9 million. Instil Bio focuses on developing innovative cell therapies for cancer treatment.

profileTIL:NASDAQAI content: aiUpdated June 24, 2026/company/instil-bio-inc/c-xernpajb
Instil Bio, Inc. logo
Ticker
TIL:NASDAQ
Asset type
Stock
Market cap
$50.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD